Literature DB >> 22982440

Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.

Patrícia H Domingues1, Cristina Teodósio, Javier Ortiz, Pablo Sousa, Alvaro Otero, Angel Maillo, Paloma Bárcena, Maria C García-Macias, Maria C Lopes, Catarina de Oliveira, Alberto Orfao, Maria D Tabernero.   

Abstract

Meningiomas are primary tumors of the central nervous system composed of both neoplastic and other infiltrating cells. We determined the cellular composition of 51 meningioma samples by multiparameter flow cytometric (MFC) immunophenotyping and investigated the potential relationship between mRNA and protein expression levels of neoplastic cells. For immunophenotypic, morphologic, and cytogenetic characterization of individual cell populations, a large panel of markers was used together with phagocytic/endocytic functional assays and MFC sorting. Overall, our results revealed coexistence of CD45(-) neoplastic cells and CD45(+) immune infiltrating cells in all meningiomas. Infiltrating cells included tissue macrophages, with an HLA-DR(+)CD14(+)CD45(+)CD68(+)CD16(-/+)CD33(-/+) phenotype and high phagocytic/endocytic activity, and a small proportion of cytotoxic lymphocytes (mostly T CD8(+) and natural killer cells). Tumor cells expressed multiple cell adhesion proteins, tetraspanins, HLA-I/HLA-DR molecules, complement regulatory proteins, cell surface ectoenzymes, and growth factor receptors. Noteworthy, the relationship between mRNA and protein levels was variable, depending on the proteins evaluated and the level of infiltration by immune cells. In summary, our results indicate that MFC immunophenotyping provides a reliable tool for the characterization of the patterns of protein expression of different cell populations coexisting in meningioma samples, with a more accurate measure of gene expression profiles of tumor cells at the functional/protein level than conventional mRNA microarray, independently of the degree of infiltration of the tumor by immune cells.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982440     DOI: 10.1016/j.ajpath.2012.07.033

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.

Authors:  Dexuan Ma; Ying Wang; Guhong Du; Jingyun Yang; Qisheng Tang; Liangfu Zhou
Journal:  Tumour Biol       Date:  2015-10-14

2.  Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations.

Authors:  Bronwyn E Hamilton; Randall L Woltjer; Joao Prola-Netto; Gary M Nesbit; Seymur Gahramanov; Thao Pham; Jaime Wagner; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

3.  Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma.

Authors:  Dustin T Proctor; Zeel Patel; Sanju Lama; Lothar Resch; Guido van Marle; Garnette R Sutherland
Journal:  Oncoimmunology       Date:  2018-09-05       Impact factor: 8.110

Review 4.  Interaction Between Innate Lymphoid Cells and the Nervous System.

Authors:  Yuanyue Zhang; Rachel Grazda; Qi Yang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma Microenvironment.

Authors:  Cathal J Hannan; Daniel Lewis; Claire O'Leary; Carmine A Donofrio; Dafydd G Evans; Emma Stapleton; Simon R Freeman; Simon K Lloyd; Scott A Rutherford; Charlotte Hammerbeck-Ward; David Brough; Stuart M Allan; David Coope; Andrew T King; Omar N Pathmanaban
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-10

6.  Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma.

Authors:  Laura Pinton; Samantha Solito; Elena Masetto; Marina Vettore; Stefania Canè; Alessandro Della Puppa; Susanna Mandruzzato
Journal:  Oncoimmunology       Date:  2018-03-15       Impact factor: 8.110

7.  The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.

Authors:  Liangjuan Fang; Daniel E Lowther; Matthew L Meizlish; Richard C E Anderson; Jeffrey N Bruce; Lesley Devine; Anita J Huttner; Steven H Kleinstein; Jae-Yun Lee; Joel N H Stern; Gur Yaari; Laura Lovato; Katharine M Cronk; Kevin C O'Connor
Journal:  Neuro Oncol       Date:  2013-08-26       Impact factor: 12.300

8.  Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.

Authors:  Shirin Karimi; Manav V Vyas; Lior Gonen; Raha Tabasinejad; Quinn T Ostrom; Jill Barnholtz-Sloan; Suganth Suppiah; Gelareh Zadeh; Kenneth Aldape
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

9.  Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome.

Authors:  María González-Tablas Pimenta; Álvaro Otero; Daniel Angel Arandia Guzman; Daniel Pascual-Argente; Laura Ruíz Martín; Pablo Sousa-Casasnovas; Andoni García-Martin; Juan Carlos Roa Montes de Oca; Javier Villaseñor-Ledezma; Luis Torres Carretero; Maria Almeida; Javie Ortiz; Adelaida Nieto; Alberto Orfao; María Dolores Tabernero
Journal:  Brain Pathol       Date:  2021-02-13       Impact factor: 6.508

10.  Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Authors:  Cristiane S Ferreira-Facio; Cristiane Milito; Vitor Botafogo; Marcela Fontana; Leandro S Thiago; Elen Oliveira; Ariovaldo S da Rocha-Filho; Fernando Werneck; Danielle N Forny; Samuel Dekermacher; Ana Paula de Azambuja; Sima Esther Ferman; Paulo Antônio Silvestre de Faria; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.